Akademisyen
BEDİA KAYMAKÇIOĞLU
PROFESÖR
BİRUNİ ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Farmasotik Kimya
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 76
- Proje 0
- Kitap 0
- Bildiri 27
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
17
Q2
23
Q3
17
Q4
3
WoS (JCR)
Q1
13
Q2
12
Q3
21
Q4
14
TR Index
7
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
1
Üst %10 makale
20
Ort. yüzdelik
69.2%
Üst %1 payı
1.6%
Üst %10 payı
31.7%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2024 Insecticidal effect of new synthesized chalcone derivatives on Caribbean fruit fly, Anastrepha suspensa YÖKSİS SJR Q3 JCR Q3 OpenAlex 79.8%
- 2024 Synthesis and molecular docking analysis of novel hydrazone and thiosemicarbazide derivatives incorporating a pyrimidine ring: exploring neuroprotective activity YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 94.5%
- 2024 Exploring 2-Pyrazoline derivatives as potent antidiabetic agents and cholinesterase inhibitors: Their synthesis and molecular docking studies YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 92.5%
- 2024 Synthesis, Characterization, Molecular Docking Studies and Biological Evaluation of Some Novel 3,5-disubstituted-1-phenyl-4,5-dihydro-1H-pyrazole Derivatives YÖKSİS SJR Q3 JCR Q3 OpenAlex 1.8%
- 2024 Synthesis, characterization, biological evaluation and in silico studies of novel 1,3,4-thiadiazole derivatives as aromatase inhibitors YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 91.2%
- 2023 Synthesis of Phthalimide Derivatives and Their Insecticidal Activity against Caribbean Fruit Fly, Anastrepha suspensa (Loew) YÖKSİS SJR Q1 JCR Q1 OpenAlex 84.2%
- 2023 Recent Advances in the Microwave and Ultrasound-Assisted Synthesis of Pyrazole Scaffolds YÖKSİS SJR Q3 JCR Q3 OpenAlex 72.3%
- 2022 Induction of Divergent Cell Death Pathways by Urea and Carbohydrazide Derivatives YÖKSİS SJR Q3 JCR Q3 OpenAlex 4.6%
- 2022 Synthesis of novel thiosemicarbazone derivatives as antidiabetic agent with enzyme kinetic studies and antioxidant activity YÖKSİS SJR Q4 JCR Q4 OpenAlex 75.7%
- 2022 Design, Synthesis, In Silico ADMET Studies and Anticancer Activity of Some New Pyrazoline and Benzodioxole Derivatives YÖKSİS SJR Q3 JCR Q4 OpenAlex 59.2%
- 2022 Design, synthesis, biological activity evaluation and in silico studies of new nicotinohydrazide derivatives as multi-targeted inhibitors for Alzheimers disease YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 92.9%
- 2022 Synthesis of some novel 1,3,4-oxadiazole derivatives and evaluation of their antimicrobial activity YÖKSİS SJR Q3 JCR Q3 OpenAlex 85.8%
- 2022 N-Substituted arylidene\u20103\u2010(methylsulfonyl)\u20102\u2010oxoimidazolidine\u20101\u2010carbohydrazide as cholinesterase inhibitors: Design, synthesis, and molecular docking study YÖKSİS SJR Q2 JCR Q3 OpenAlex 78.0%
- 2021 Synthesis, anticancer evaluation and in silico ADMET studies on urea/thiourea derivatives from gabapentin YÖKSİS SJR Q4 JCR Q4 OpenAlex 56.6%
- 2021 Synthesis of new hydrazone derivatives and evaluation of their monoamine oxidase inhibitory activity YÖKSİS SJR Q2 JCR Q1 OpenAlex üst %10 OpenAlex 96.8%
- 2021 Novel 2,5-disubstituted-1,3,4-oxadiazole derivatives as MAO-B inhibitors: Synthesis, biological evaluation and molecular modeling studies YÖKSİS SJR Q2 JCR Q1 OpenAlex üst %10 OpenAlex 94.3%
- 2020 Design, synthesis and biological evaluation of some new 2-Pyrazolinederivatives as potential anticancer agents YÖKSİS SJR Q2 JCR Q1 OpenAlex üst %10 OpenAlex 91.9%
- 2019 Design, synthesis, biological evaluation and molecular docking of novel moleculesto PARP-1 enzyme YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 68.3%
- 2019 Synthesis and biological evaluation of new pyrazolone Schiff bases as monoamine oxidase and cholinesterase inhibitors YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 94.3%
- 2019 Synthesis and Anticancer Activity of New Hydrazide-hydrazones and Their Pd(II) Complexes YÖKSİS SJR Q2 JCR Q4 OpenAlex 58.1%